Evidence map›Paper›PMID 41057760›Full record

ArticleBMC infectious diseases2025

Analysis of clinical and bronchoscopic features of multidrug-resistant tracheobronchial tuberculosis.

Jian Li, Xue Li, Lulu Qiu, Guoyi Huang, Jiamin Huang, Zhichao Liu, Xue Ke, Xiufen Wang, Wenying Gao, Guobao Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jian LiNational Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.
Xue LiNational Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.
Lulu QiuNational Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.
Guoyi HuangNational Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.
Jiamin HuangNational Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.
Zhichao LiuNational Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.
Xue KeNational Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.
Xiufen WangNational Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, The Second Affiliated Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen, People's Republic of China.
Wenying GaoShenzhen Clinical Research Center for Tuberculosis, Shenzhen, People's Republic of China.
Guobao LiShenzhen Clinical Research Center for Tuberculosis, Shenzhen, People's Republic of China. L3gb@qq.com.

Funding

Shenzhen Clinical Research Center for Tuberculosis 20210617141509001
6 · The paper itself

Abstract

objectiveInvestigate patients' clinical characteristics and bronchoscopic features with multidrug-resistant tracheobronchial tuberculosis.

methodsA total of 118 patients with confirmed diagnosis of multidrug-resistant tracheobronchial tuberculosis were selected retrospectively, and the demographic data, clinical characteristics, and bronchoscopic manifestations were analyzed.

resultsAmong patients with multidrug-resistant tracheobronchial tuberculosis, the main clinical features were cough (92.3%,109/118) and sputum (83.0%,98/118). The primary infection sites of multidrug-resistant tuberculosis were the right upper bronchus (39.8%,47/118) and the left upper bronchus (37.3%,44/118). The main types of multidrug-resistant tracheobronchial tuberculosis lesions were inflammatory infiltration type (46.6%,55/118) and necrosis type (32.2%,38/118).

conclusionThe clinical manifestations of multidrug-resistant tracheobronchial tuberculosis are non-specific. The main clinical features are cough and fever. It often invades the right upper bronchus. The main bronchoscopic manifestation is inflammatory infiltration.

Indexed as

Tuberculosis, Multidrug-ResistantAdolescentAdultAgedAntitubercular AgentsBronchiBronchial DiseasesBronchoscopyCoughFemaleHumansMaleMiddle AgedMycobacterium tuberculosisRetrospective StudiesYoung AdultAntitubercular AgentsBronchoscopyCharacteristicsClinical featuresMultidrug resistanceTracheobronchial tuberculosis

Identifiers

PMID41057760
PMCPMC12502215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.